COVID-19" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047369). BMC Medicine. 18 (1): 57. doi:10.1186/s12916-020-01533-w (https://doi.org/10.1186%2Fs12916-020-01533-w). PMC 7047369 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047369). PMID 32106852 (htt ps://pubmed.ncbi.nlm.nih.gov/32106852). 44. Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. (May 2020). "Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province" (https://www.ncbi.nlm.nih.gov/p mc/articles/PMC7147277). Chinese Medical Journal. 133 (9): 1025–1031. doi:10.1097/CM9.0000000000000744 (https://doi.org/10.1097%2FCM9.0000000000000744). PMC 7147277 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147277). PMID 32044814 (htt ps://pubmed.ncbi.nlm.nih.gov/32044814). 45. Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Y, Jiang B (March 2020). "Comorbidities and multi- organ injuries in the treatment of COVID-19". Lancet. Elsevier BV. 395 (10228): e52. doi:10.1016/s0140-6736(20)30558-4 (https://doi.org/10.1016%2Fs0140-6736%2820%293055 8-4). PMID 32171074 (https://pubmed.ncbi.nlm.nih.gov/32171074). 46. Henry BM (April 2020). "COVID-19, ECMO, and lymphopenia: a word of caution" (https://www. ncbi.nlm.nih.gov/pmc/articles/PMC7118650). The Lancet. Respiratory Medicine. Elsevier BV. 8 (4): e24. doi:10.1016/s2213-2600(20)30119-3 (https://doi.org/10.1016%2Fs2213-2600%282 0%2930119-3). PMC 7118650 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118650). PMID 32178774 (https://pubmed.ncbi.nlm.nih.gov/32178774). 47. Wang L, Wang Y, Ye D, Liu Q (March 2020). "Review of the 2019 novel coronavirus (SARS- CoV-2) based on current evidence" (https://www.sciencedirect.com/science/article/pii/S092485 7920300984). International Journal of Antimicrobial Agents: 105948. doi:10.1016/j.ijantimicag.2020.105948 (https://doi.org/10.1016%2Fj.ijantimicag.2020.105948). PMC 7156162 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156162). PMID 32201353 (htt ps://pubmed.ncbi.nlm.nih.gov/32201353). Archived (https://web.archive.org/web/20200327232 545/https://www.sciencedirect.com/science/article/pii/S0924857920300984) from the original on 27 March 2020. Retrieved 27 March 2020. 48. Wang Y, Wang Y, Chen Y, Qin Q (March 2020). "Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228347). Journal of Medical Virology. n/a (n/a): 568–576. doi:10.1002/jmv.25748 (https://doi.org/10.1002%2Fjmv.25748). PMC 7228347 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228347). PMID 32134116 (htt ps://pubmed.ncbi.nlm.nih.gov/32134116). 49. Cheng ZJ, Shan J (April 2020). "2019 Novel coronavirus: where we are and what we know" (ht tps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095345). Infection. 48 (2): 155–163. doi:10.1007/s15010-020-01401-y (https://doi.org/10.1007%2Fs15010-020-01401-y). PMC 7095345 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095345). PMID 32072569 (htt ps://pubmed.ncbi.nlm.nih.gov/32072569). 50. "Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected" (https://www.who.int/publications-detail/clinical-management-of-severe- acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected). World Health Organization (WHO). Archived (https://web.archive.org/web/20200131032122/https://w ww.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when -novel-coronavirus-(ncov)-infection-is-suspected) from the original on 31 January 2020. Retrieved 13 February 2020. 51. Farkas J (March 2020). COVID-19—The Internet Book of Critical Care (https://emcrit.org/ibcc/c ovid19/) (digital) (Reference manual). USA: EMCrit. Archived (https://web.archive.org/web/202 00311195758/https://emcrit.org/ibcc/covid19/) from the original on 11 March 2020. Retrieved 13 March 2020. 52. "COVID19—Resources for Health Care Professionals" (https://guides.library.upenn.edu/covid- 19). Penn Libraries. 11 March 2020. Archived (https://web.archive.org/web/20200314035631/h ttps://guides.library.upenn.edu/covid-19) from the original on 14 March 2020. Retrieved 13 March 2020. 53. "Frequently Asked Questions on the Emergency Use Authorization for Remdesivir for Certain Hospitalized COVID‐19 Patients" (https://www.fda.gov/media/137574/download) (PDF). U.S. Food and Drug Administration (FDA). 1 May 2020. Retrieved 1 May 2020. This article incorporates text from this source, which is in the public domain. 54. Day M (March 2020). "Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists" (https://www.bmj.com/content/368/bmj.m1086). BMJ. 368: m1086. doi:10.1136/bmj.m1086 (https://doi.org/10.1136%2Fbmj.m1086). PMID 32184201 (https://pub med.ncbi.nlm.nih.gov/32184201). Archived (https://web.archive.org/web/20200319181945/http s://www.bmj.com/content/368/bmj.m1086) from the original on 19 March 2020. Retrieved 18 March 2020. 55. "Self-isolation advice—Coronavirus (COVID-19)" (https://www.nhs.uk/conditions/coronavirus-c ovid-19/self-isolation-advice/). National Health Service (United Kingdom). 28 February 2020. Archived (https://web.archive.org/web/20200328000128/https://www.nhs.uk/conditions/corona virus-covid-19/self-isolation-advice/) from the original on 28 March 2020. Retrieved 27 March 2020. 56. Godoy M (18 March 2020). "Concerned About Taking Ibuprofen For Coronavirus Symptoms? Here's What Experts Say" (https://www.npr.org/sections/health-shots/2020/03/18/818026613/a dvice-from-france-to-avoid-ibuprofen-for-covid-19-leaves-experts-baffled). NPR. Retrieved 8 April 2020. 57. AFP (19 March 2020). "Updated: WHO Now Doesn't Recommend Avoiding Ibuprofen For COVID-19 Symptoms" (https://www.sciencealert.com/who-recommends-to-avoid-taking-ibupro fen-for-covid-19-symptoms). ScienceAlert. Archived (https://web.archive.org/web/2020031822 2020/https://www.sciencealert.com/who-recommends-to-avoid-taking-ibuprofen-for-covid-19-sy mptoms) from the original on 18 March 2020. Retrieved 19 March 2020. 58. Research, Center for Drug Evaluation and (19 March 2020). "FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19" (https://www.fda.gov/drugs/dru g-safety-and-availability/fda-advises-patients-use-non-steroidal-anti-inflammatory-drugs-nsaids -covid-19). Drug Safety and Availability. Archived (https://web.archive.org/web/2020032719463 3/https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-patients-use-non-steroidal -anti-inflammatory-drugs-nsaids-covid-19) from the original on 27 March 2020. Retrieved 27 March 2020. 59. "Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician" (https://web.archive.org/web/20200321172112/https://ww w.hfsa.org/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unl ess-otherwise-advised-by-their-physician/). Archived from the original (https://www.hfsa.org/pat ients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise -advised-by-their-physician/) on 21 March 2020. Retrieved 21 March 2020. 60. "Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician" (https://newsroom.heart.org/news/patients-taking-ace-i-a nd-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-p hysician). American Heart Association (Press release). 17 March 2020. Archived (https://web.a rchive.org/web/20200324050912/https://newsroom.heart.org/news/patients-taking-ace-i-and-ar bs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physici an) from the original on 24 March 2020. Retrieved 25 March 2020. 61. de Simone G. "Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers" (https://www.escardio.org/Councils/Council-on-Hypertension- (CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and- ang). Council on Hypertension of the European Society of Cardiology. Archived (https://web.ar chive.org/web/20200324073257/https://www.escardio.org/Councils/Council-on-Hypertension- (CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang) from the original on 24 March 2020. Retrieved 24 March 2020. 62. "New Evidence Concerning Safety of ACE Inhibitors, ARBs in COVID-19" (https://www.pharma cytimes.com/news/new-evidence-concerning-safety-of-ace-inhibitors-arbs-in-covid-19). Pharmacy Times. Retrieved 2 May 2020. 63. Vetter P, Eckerle I, Kaiser L (February 2020). "Covid-19: a puzzle with many missing pieces". BMJ. 368: m627. doi:10.1136/bmj.m627 (https://doi.org/10.1136%2Fbmj.m627). PMID 32075791 (https://pubmed.ncbi.nlm.nih.gov/32075791). 64. "Novel Coronavirus—COVID-19: What Emergency Clinicians Need to Know" (https://www.ebm edicine.net/topics/infectious-disease/COVID-19). www.ebmedicine.net. Archived (https://web.a rchive.org/web/20200314163512/https://www.ebmedicine.net/topics/infectious-disease/COVID -19) from the original on 14 March 2020. Retrieved 9 March 2020. 65. Tang N, Bai H, Chen X, Gong J, Li D, Sun Z (May 2020). "Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy". Journal of Thrombosis and Haemostasis. 18 (5): 1094–1099. doi:10.1111/jth.14817 (https://doi.org/10.1111%2Fjth.14817). PMID 32220112 (https://pubme d.ncbi.nlm.nih.gov/32220112). 66. "Sequence for Putting On Personal Protective Equipment (PPE)" (https://www.cdc.gov/hai/pdf s/ppe/PPE-Sequence.pdf) (PDF). Centers for Disease Control and Prevention (CDC). Archived (https://web.archive.org/web/20200305173617/https://www.cdc.gov/hai/pdfs/ppe/ppe-sequenc e.pdf) (PDF) from the original on 5 March 2020. Retrieved 8 March 2020. 67. Cheung JC, Ho LT, Cheng JV, Cham EY, Lam KN (April 2020). "Staff safety during emergency airway management for COVID-19 in Hong Kong" (https://www.ncbi.nlm.nih.gov/pmc/articles/P MC7128208). The Lancet. Respiratory Medicine. 8 (4): e19. doi:10.1016/s2213- 2600(20)30084-9 (https://doi.org/10.1016%2Fs2213-2600%2820%2930084-9). PMC 7128208 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128208). PMID 32105633 (https://pubmed.nc bi.nlm.nih.gov/32105633). 68. "What healthcare personnel should know about caring for patients with confirmed or possible coronavirus disease 2" (https://www.cdc.gov/coronavirus/2019-ncov/hcp/caring-for-patients-H. pdf) (PDF). Centers for Disease Control and Prevention (CDC). 12 March 2020. Retrieved 31 March 2020. 69. "Coronavirus Disease 2019 (COVID-19)" (https://www.cdc.gov/coronavirus/2019-ncov/infection -control/control-recommendations.html). Centers for Disease Control and Prevention (CDC). 11 February 2020. Archived (https://web.archive.org/web/20200304165907/https://www.cdc.go v/coronavirus/2019-ncov/infection-control/control-recommendations.html) from the original on 4 March 2020. Retrieved 11 March 2020. 70. "Coronavirus Disease 2019 (COVID-19)" (https://www.cdc.gov/coronavirus/2019-ncov/hcp/cari ng-for-patients.html). Centers for Disease Control and Prevention (CDC). 11 February 2020. Archived (https://web.archive.org/web/20200304165907/https://www.cdc.gov/coronavirus/2019 -ncov/hcp/caring-for-patients.html) from the original on 4 March 2020. Retrieved 8 March 2020. 71. "Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings" (https://www.cdc.go v/coronavirus/2019-ncov/infection-control/control-recommendations.html). Centers for Disease Control and Prevention (CDC). 11 February 2020. Archived (https://web.archive.org/web/2020 0304165907/https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommenda tions.html) from the original on 4 March 2020. Retrieved 25 March 2020. 72. "Coronavirus Disease 2019 (COVID-19) Frequently Asked Questions" (https://www.fda.gov/em ergency-preparedness-and-response/mcm-issues/coronavirus-disease-2019-covid-19-frehttp s://oc.wikipedia.org/wiki/Malauti%C3%A1_de_coronavirus_de_2019quently-asked-questions# 5e78ba94b86da). Food and Drug Administration. 73. "Strategies for Optimizing the Supply of Facemasks" (https://www.cdc.gov/coronavirus/2019-nc ov/hcp/ppe-strategy/face-masks.html). Centers for Disease Control and Prevention (CDC). 11 February 2020. Archived (https://web.archive.org/web/20200323173927/https://www.cdc.gov/c oronavirus/2019-ncov/hcp/ppe-strategy/face-masks.html) from the original on 23 March 2020. Retrieved 23 March 2020. 74. Murthy S, Gomersall CD, Fowler RA (March 2020). "Care for Critically Ill Patients With COVID- 19" (https://jamanetwork.com/journals/jama/fullarticle/2762996). JAMA. 323 (15): 1499. doi:10.1001/jama.2020.3633 (https://doi.org/10.1001%2Fjama.2020.3633). PMID 32159735 (h ttps://pubmed.ncbi.nlm.nih.gov/32159735). Archived (https://web.archive.org/web/2020031820 3852/https://jamanetwork.com/journals/jama/fullarticle/2762996) from the original on 18 March 2020. Retrieved 18 March 2020. 75. World Health Organization (28 January 2020). "Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected" (https://www. who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf) (PDF). Archived (https://web.archive.org/web/20200226041620/https://www.who.int/docs/default-sour ce/coronaviruse/clinical-management-of-novel-cov.pdf) (PDF) from the original on 26 February 2020. Retrieved 18 March 2020. 76. Wang K, Zhao W, Li J, Shu W, Duan J (March 2020). "The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104710). Annals of Intensive Care. 10 (1): 37. doi:10.1186/s13613-020-00653-z (https://doi.org/10.118 6%2Fs13613-020-00653-z). PMC 7104710 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC71 04710). PMID 32232685 (https://pubmed.ncbi.nlm.nih.gov/32232685). 77. McEnery T, Gough C, Costello RW (April 2020). "COVID-19: Respiratory support outside the intensive care unit" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146718). The Lancet. Respiratory Medicine. doi:10.1016/S2213-2600(20)30176-4 (https://doi.org/10.1016%2FS2213 -2600%2820%2930176-4). PMC 7146718 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC714 6718). PMID 32278367 (https://pubmed.ncbi.nlm.nih.gov/32278367). 78. Cummings, Matthew J.; Baldwin, Matthew R.; Abrams, Darryl; Jacobson, Samuel D.; Meyer, Benjamin J.; Balough, Elizabeth M.; Aaron, Justin G.; Claassen, Jan; Rabbani, LeRoy E.; Hastie, Jonathan; Hochman, Beth R. (19 May 2020). "Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study" (ht tps://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31189-2/abstract). The Lancet. 0. doi:10.1016/S0140-6736(20)31189-2 (https://doi.org/10.1016%2FS0140-6736%282 0%2931189-2). ISSN 0140-6736 (https://www.worldcat.org/issn/0140-6736). 79. Scott, Dylan (16 March 2020). "Coronavirus is exposing all of the weaknesses in the US health system High health care costs and low medical capacity made the US uniquely vulnerable to the coronavirus" (https://www.vox.com/policy-and-politics/2020/3/16/21173766/coronavirus-cov id-19-us-cases-health-care-system). Vox. Archived (https://web.archive.org/web/20200318022 237/https://www.vox.com/policy-and-politics/2020/3/16/21173766/coronavirus-covid-19-us-cas es-health-care-system) from the original on 18 March 2020. Retrieved 18 March 2020. 80. Matthay MA, Aldrich JM, Gotts JE (May 2020). "Treatment for severe acute respiratory distress syndrome from COVID-19" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118607). The Lancet. Respiratory Medicine. 8 (5): 433–434. doi:10.1016/S2213-2600(20)30127-2 (https://do i.org/10.1016%2FS2213-2600%2820%2930127-2). PMC 7118607 (https://www.ncbi.nlm.nih.g ov/pmc/articles/PMC7118607). PMID 32203709 (https://pubmed.ncbi.nlm.nih.gov/32203709). 81. Briel M, Meade M, Mercat A, Brower RG, Talmor D, Walter SD, et al. (March 2010). "Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis". JAMA. 303 (9): 865–73. doi:10.1001/jama.2010.218 (https://doi.org/10.1001%2Fjama.2010.218). PMID 20197533 (http s://pubmed.ncbi.nlm.nih.gov/20197533). 82. Diaz R, Heller D (2020). Barotrauma And Mechanical Ventilation (https://www.ncbi.nlm.nih.gov/ books/NBK545226/). StatPearls. StatPearls Publishing. PMID 31424810 (https://pubmed.ncbi. nlm.nih.gov/31424810). 83. "Chinese doctors using plasma therapy on coronavirus, WHO says 'very valid' approach" (http s://www.reuters.com/article/us-china-health-hospital-idUSKBN20B1M6). Reuters. 17 February 2020. Archived (https://web.archive.org/web/20200304173709/https://www.reuters.com/article/ us-china-health-hospital-idUSKBN20B1M6) from the original on 4 March 2020. Retrieved 19 March 2020. 84. Steenhuysen J, Kelland K (24 January 2020). "With Wuhan virus genetic code in hand, scientists begin work on a vaccine" (https://www.reuters.com/article/us-china-health-vaccines-i dUSKBN1ZN2J8). Reuters. Archived (https://web.archive.org/web/20200125203723/https://ww w.reuters.com/article/us-china-health-vaccines-idUSKBN1ZN2J8) from the original on 25 January 2020. Retrieved 25 January 2020. 85. Duddu P (19 February 2020). "Coronavirus outbreak: Vaccines/drugs in the pipeline for Covid- 19" (https://web.archive.org/web/20200219184512/https://www.clinicaltrialsarena.com/analysi s/coronavirus-mers-cov-drugs/). clinicaltrialsarena.com. Archived from the original (https://ww w.clinicaltrialsarena.com/analysis/coronavirus-mers-cov-drugs/) on 19 February 2020. 86. Lu H (March 2020). "Drug treatment options for the 2019-new coronavirus (2019-nCoV)". Bioscience Trends. 14 (1): 69–71. doi:10.5582/bst.2020.01020 (https://doi.org/10.5582%2Fbst. 2020.01020). PMID 31996494 (https://pubmed.ncbi.nlm.nih.gov/31996494). 87. Li G, De Clercq E (March 2020). "Therapeutic options for the 2019 novel coronavirus (2019- nCoV)". Nature Reviews. Drug Discovery. 19 (3): 149–150. doi:10.1038/d41573-020-00016-0 (https://doi.org/10.1038%2Fd41573-020-00016-0). PMID 32127666 (https://pubmed.ncbi.nlm.n ih.gov/32127666). 88. Nebehay S, Kelland K, Liu R (5 February 2020). "WHO: 'no known effective' treatments for new coronavirus" (https://www.reuters.com/article/us-china-health-treatments-who-idUSKBN1Z Z1M6). Thomson Reuters. Archived (https://web.archive.org/web/20200205155653/https://ww w.reuters.com/article/us-china-health-treatments-who-idUSKBN1ZZ1M6) from the original on 5 February 2020. Retrieved 5 February 2020. 89. "Blood plasma taken from covid-19 survivors might help patients fight off the disease" (https:// www.technologyreview.com/2020/04/08/998700/blood-plasma-taken-from-covid-19-survivors- might-help-patients-fight-it-off/). MIT Technology Review. 90. "Trials of Plasma From Recovered Covid-19 Patients Have Begun" (https://www.wired.com/sto ry/trials-of-plasma-from-recovered-covid-19-patients-have-begun/). Wired. 91. "FDA now allows treatment of life-threatening COVID-19 cases using blood from patients who have recovered" (https://social.techcrunch.com/2020/03/24/fda-now-allows-treatment-of-life-thr eatening-covid-19-cases-using-blood-from-patients-who-have-recovered/). TechCrunch. Retrieved 9 April 2020. 92. "China launches coronavirus 'close contact' app" (https://www.bbc.com/news/technology-5143 9401). BBC News. 11 February 2020. Archived (https://web.archive.org/web/2020022800395 7/https://www.bbc.com/news/technology-51439401) from the original on 28 February 2020. Retrieved 7 March 2020. 93. Chen A. "China's coronavirus app could have unintended consequences" (https://www.technol ogyreview.com/s/615199/coronavirus-china-app-close-contact-surveillance-covid-19-technolog y/). MIT Technology Review. Retrieved 7 March 2020. 94. "Gov in the Time of Corona" (https://govinsider.asia/innovation/gov-in-the-time-of-corona/). GovInsider. 19 March 2020. Archived (https://web.archive.org/web/20200320125215/https://go vinsider.asia/innovation/gov-in-the-time-of-corona/) from the original on 20 March 2020. Retrieved 20 March 2020. 95. Manancourt V (10 March 2020). "Coronavirus tests Europe's resolve on privacy" (https://www. politico.eu/article/coronavirus-tests-europe-resolve-on-privacy-tracking-apps-germany-italy/). POLITICO. Archived (https://web.archive.org/web/20200320105744/https://www.politico.eu/arti cle/coronavirus-tests-europe-resolve-on-privacy-tracking-apps-germany-italy/) from the original on 20 March 2020. Retrieved 20 March 2020. 96. Tidy J (17 March 2020). "Coronavirus: Israel enables emergency spy powers" (https://www.bb c.com/news/technology-51930681). BBC News. Archived (https://web.archive.org/web/202003 18113608/https://www.bbc.com/news/technology-51930681) from the original on 18 March 2020. Retrieved 18 March 2020. 97. Bünte O (18 March 2020). "Corona-Krise: Deutsche Telekom liefert anonymisierte Handydaten an RKI" (https://www.heise.de/newsticker/meldung/Corona-Krise-Deutsche-Telekom-liefert-ano nymisierte-Handydaten-an-RKI-4685191.html) [Corona crisis: Deutsche Telekom delivers anonymized cell phone data to RKI]. Heise Online (in German). Archived (https://web.archive.o rg/web/20200324115410/https://www.heise.de/newsticker/meldung/Corona-Krise-Deutsche-Te lekom-liefert-anonymisierte-Handydaten-an-RKI-4685191.html) from the original on 24 March 2020. Retrieved 25 March 2020. 98. "Moscow deploys facial recognition technology for coronavirus quarantine" (https://www.reuter s.com/article/us-china-health-moscow-technology-idUSKBN20F1RZ). Reuters. 21 February 2020. Archived (https://web.archive.org/web/20200222215731/https://www.reuters.com/article/ us-china-health-moscow-technology-idUSKBN20F1RZ) from the original on 22 February 2020. Retrieved 20 March 2020. 99. "Italians scolded for flouting lockdown as death toll nears 3,000" (https://www.post-gazette.co m/news/world/2020/03/18/Italy-coronavirus-475-deaths-one-day-death-toll-2978-COVID-19-do ctors/stories/202003180182). Pittsburgh Post-Gazette. Archived (https://web.archive.org/web/2 0200320110555/https://www.post-gazette.com/news/world/2020/03/18/Italy-coronavirus-475-d eaths-one-day-death-toll-2978-COVID-19-doctors/stories/202003180182) from the original on 20 March 2020. Retrieved 20 March 2020. 00. "Kreative Lösungen gesucht" (https://www.bundesregierung.de/breg-de/themen/coronavirus/wi r-vs-virus-1731968). Startseite (in German). Archived (https://web.archive.org/web/202003240 85627/https://www.bundesregierung.de/breg-de/themen/coronavirus/wir-vs-virus-1731968) from the original on 24 March 2020. Retrieved 23 March 2020. 01. Dannewitz J (23 March 2020). "Hackathon Germany: #WirvsVirus" (https://www.datenschutzbe auftragter-info.de/hackathon-germany-wirvsvirus/). Datenschutzbeauftragter (in German). 02. Staff (8 April 2020). "Lockdown is working, suggests latest data from symptom tracker app" (htt ps://www.kcl.ac.uk/news/lockdown-is-working-suggests-latest-data-from-symptom-tracker- app). Kings College London News Centre. Retrieved 20 April 2020. 03. Lydall, Ross (4 May 2020). "Three million download app to track coronavirus symptoms" (http s://www.standard.co.uk/news/techandgadgets/three-million-download-app-to-track-symptoms- a4431271.html). Evening Standard. Retrieved 8 May 2020. 04. Whyte A (21 March 2020). "President makes global call to combat coronavirus via hackathon" (https://news.err.ee/1067171/president-makes-global-call-to-combat-coronavirus-via-hackatho n). ERR. Archived (https://web.archive.org/web/20200324050421/https://news.err.ee/1067171/ president-makes-global-call-to-combat-coronavirus-via-hackathon) from the original on 24 March 2020. Retrieved 23 March 2020. 05. Xiang YT, Yang Y, Li W, Zhang L, Zhang Q, Cheung T, Ng CH (March 2020). "Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed" (https://www.ncbi.nlm. nih.gov/pmc/articles/PMC7128153). The Lancet. Psychiatry. 7 (3): 228–229. doi:10.1016/S2215-0366(20)30046-8 (https://doi.org/10.1016%2FS2215-0366%2820%293004 6-8). PMC 7128153 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128153). PMID 32032543 (https://pubmed.ncbi.nlm.nih.gov/32032543). 06. Kang L, Li Y, Hu S, Chen M, Yang C, Yang BX, et al. (March 2020). "The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus" (https://www.ncbi.n lm.nih.gov/pmc/articles/PMC7129673). The Lancet. Psychiatry. 7 (3): e14. doi:10.1016/S2215- 0366(20)30047-X (https://doi.org/10.1016%2FS2215-0366%2820%2930047-X). PMC 7129673 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129673). PMID 32035030 (htt ps://pubmed.ncbi.nlm.nih.gov/32035030). 07. Coronavirus: 'Profound' mental health impact prompts calls for urgent research (https://www.bb c.com/news/health-52295894), BBC, Philippa Roxby, 16 April 2020. 08. Multidisciplinary research priorities for the COVID‑19 pandemic: a call for action for mental health science (https://www.thelancet.com/pdfs/journals/lanpsy/PIIS2215-0366(20)30168-1.pd f), The Lancet, Emily Holmes, Rory O'Connor, Hugh Perry, et al., 15 April 2020, page 1: "A fragmented research response, characterised by small-scale and localised initiatives, will not yield the clear insights necessary to guide policymakers or the public." 09. Roser M, Ritchie H, Ortiz-Ospina E (4 March 2020). "Coronavirus Disease (COVID-19)" (http s://ourworldindata.org/coronavirus). Our World in Data. Archived (https://web.archive.org/web/ 20200319171947/https://ourworldindata.org/coronavirus) from the original on 19 March 2020. Retrieved 12 March 2020. 10. Yanping Z, et al. (The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team) (17 February 2020). "The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)—China, 2020" (http://weekly.chinacdc.cn/en/article/id/e539 46e2-c6c4-41e9-9a9b-fea8db1a8f51). China CDC Weekly. Chinese Center for Disease Control and Prevention. 2 (8): 113–122. Archived (https://web.archive.org/web/202002191421 01/http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51) from the original on 19 February 2020. Retrieved 18 March 2020. 11. 코로나바이러스감염증-19 국내 발생 현황 (5월 24일) (https://www.cdc.go.kr/board/board.es?mi d=a20501000000&bid=0015&list_no=367317&act=view) (Report). Korea Centers for Disease Control and Prevention. 24 May 2020. Retrieved 24 May 2020. 12. Actualización nº 109. Enfermedad por el coronavirus (COVID-19) (https://www.mscbs.gob.es/p rofesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Actualizacion_109_C OVID-19.pdf) (PDF) (Report) (in Spanish). Ministerio de Sanidad, Consumo y Bienestar Social. 18 May 2020. Retrieved 20 May 2020. 13. Epidemia COVID-19. Aggiornamento nazionale 14 maggio 2020 (https://www.epicentro.iss.it/c oronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_14-maggio-2020.pdf) (PDF) (Report) (in Italian). Rome: Istituto Superiore di Sanità. 15 May 2020. Retrieved 21 May 2020. 14. Roser M, Ritchie H, Ortiz-Ospina E (6 April 2020). "Coronavirus Disease (COVID-19)" (https:// ourworldindata.org/coronavirus). Our World in Data. Retrieved 6 April 2020. 15. Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al. (April 2020). "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review" (https://jamanetwork.com/journals/jamapediatrics/fullarticl e/2765169). JAMA Pediatrics. doi:10.1001/jamapediatrics.2020.1467 (https://doi.org/10.1001% 2Fjamapediatrics.2020.1467). PMID 32320004 (https://pubmed.ncbi.nlm.nih.gov/32320004). 16. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. (April 2020). "SARS-CoV-2 Infection in Children" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121177). The New England Journal of Medicine. Massachusetts Medical Society. 382 (17): 1663–1665. doi:10.1056/nejmc2005073 (https://doi.org/10.1056%2Fnejmc2005073). PMC 7121177 (http s://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121177). PMID 32187458 (https://pubmed.ncbi.nl m.nih.gov/32187458). 17. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S (March 2020). "Epidemiology of COVID-19 Among Children in China" (https://pediatrics.aappublications.org/content/pediatrics/early/2020/ 03/16/peds.2020-0702.full.pdf) (PDF). Pediatrics: e20200702. doi:10.1542/peds.2020-0702 (ht tps://doi.org/10.1542%2Fpeds.2020-0702). PMID 32179660 (https://pubmed.ncbi.nlm.nih.gov/ 32179660). Archived (https://web.archive.org/web/20200317223427/https://pediatrics.aappubli cations.org/content/pediatrics/early/2020/03/16/peds.2020-0702.full.pdf) (PDF) from the original on 17 March 2020. Retrieved 16 March 2020. 18. Fang L, Karakiulakis G, Roth M (April 2020). "Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?" (https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC7118626). The Lancet. Respiratory Medicine. 8 (4): e21. doi:10.1016/S0140- 6736(20)30311-1 (https://doi.org/10.1016%2FS0140-6736%2820%2930311-1). PMC 7118626 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118626). PMID 32171062 (https://pubmed.nc bi.nlm.nih.gov/32171062). 19. "Coronavirus Disease 2019 (COVID-19)" (https://www.cdc.gov/coronavirus/2019-ncov/specific- groups/children-faq.html). Centers for Disease Control and Prevention (CDC). 11 February 2020. Archived (https://web.archive.org/web/20200302064104/https://www.cdc.gov/coronaviru s/2019-ncov/specific-groups/children-faq.html) from the original on 2 March 2020. Retrieved 2 March 2020. 20. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. (March 2020). "Dysregulation of immune response in patients with COVID-19 in Wuhan, China" (https://www.ncbi.nlm.nih.gov/pmc/articl es/PMC7108125). Clinical Infectious Diseases. doi:10.1093/cid/ciaa248 (https://doi.org/10.109 3%2Fcid%2Fciaa248). PMC 7108125 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC710812 5). PMID 32161940 (https://pubmed.ncbi.nlm.nih.gov/32161940). 21. "WHO Director-General's statement on the advice of the IHR Emergency Committee on Novel Coronavirus" (https://www.who.int/dg/speeches/detail/who-director-general-s-statement-on-the -advice-of-the-ihr-emergency-committee-on-novel-coronavirus). World Health Organization (WHO). 22. Palmieri L, Andrianou X, Barbariol P, Bella A, Bellino S, Benelli E, et al. (3 April 2020). Characteristics of COVID-19 patients dying in Italy Report based on available data on April 2th, 2020 (https://www.epicentro.iss.it/en/coronavirus/bollettino/Report-COVID-2019_2_april_2 020.pdf) (PDF) (Report). Istituto Superiore di Sanità. Retrieved 3 April 2020. 23. Wang W, Tang J, Wei F (April 2020). "Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC71 67192). Journal of Medical Virology. 92 (4): 441–447. doi:10.1002/jmv.25689 (https://doi.org/1 0.1002%2Fjmv.25689). PMC 7167192 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC716719 2). PMID 31994742 (https://pubmed.ncbi.nlm.nih.gov/31994742). 24. "Coronavirus Age, Sex, Demographics (COVID-19)" (https://www.worldometers.info/coronaviru s/coronavirus-age-sex-demographics/). www.worldometers.info. Archived (https://web.archive. org/web/20200227112932/https://www.worldometers.info/coronavirus/coronavirus-age-sex-de mographics/) from the original on 27 February 2020. Retrieved 26 February 2020. 25. Garg S, Kim L, Whitaker M, O'Halloran A, Cummings C, Holstein R, et al. (April 2020). "Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020" (https://www.cdc.gov/ mmwr/volumes/69/wr/mm6915e3.htm). MMWR. Morbidity and Mortality Weekly Report. 69 (15): 458–464. doi:10.15585/mmwr.mm6915e3 (https://doi.org/10.15585%2Fmmwr.mm6915e 3). PMID 32298251 (https://pubmed.ncbi.nlm.nih.gov/32298251). 26. Ji Y, Ma Z, Peppelenbosch MP, Pan Q (April 2020). "Potential association between COVID-19 mortality and health-care resource availability" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC 7128131). The Lancet. Global Health. 8 (4): e480. doi:10.1016/S2214-109X(20)30068-1 (http s://doi.org/10.1016%2FS2214-109X%2820%2930068-1). PMC 7128131 (https://www.ncbi.nl m.nih.gov/pmc/articles/PMC7128131). PMID 32109372 (https://pubmed.ncbi.nlm.nih.gov/3210 9372). 27. Li XQ, Cai WF, Huang LF, Chen C, Liu YF, Zhang ZB, et al. (March 2020). "[Comparison of epidemic characteristics between SARS in2003 and COVID-19 in 2020 in Guangzhou]". Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi (in Chinese). 41 (5): 634–637. doi:10.3760/cma.j.cn112338-20200228-00209 (https://doi.org/10.3760%2Fcma.j.cn1 12338-20200228-00209). PMID 32159317 (https://pubmed.ncbi.nlm.nih.gov/32159317). 28. Jung SM, Akhmetzhanov AR, Hayashi K, Linton NM, Yang Y, Yuan B, et al. (February 2020). "Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074479). Journal of Clinical Medicine. 9 (2): 523. doi:10.3390/jcm9020523 (https://doi.org/10.3390%2Fjc m9020523). PMC 7074479 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074479). PMID 32075152 (https://pubmed.ncbi.nlm.nih.gov/32075152). 29. Chughtai AA, Malik AA (March 2020). "Is Coronavirus disease (COVID-19) case fatality ratio underestimated?" (https://jglobalbiosecurity.com/articles/10.31646/gbio.56/). Global Biosecurity. 1 (3). doi:10.31646/gbio.56 (https://doi.org/10.31646%2Fgbio.56) (inactive 26 April 2020). 30. Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G (March 2020). "Real estimates of mortality following COVID-19 infection" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC711851 5). The Lancet. Infectious Diseases. doi:10.1016/S1473-3099(20)30195-X (https://doi.org/10.1 016%2FS1473-3099%2820%2930195-X). PMC 7118515 (https://www.ncbi.nlm.nih.gov/pmc/ar ticles/PMC7118515). PMID 32171390 (https://pubmed.ncbi.nlm.nih.gov/32171390). 31. Vardavas CI, Nikitara K (20 March 2020). "COVID-19 and smoking: A systematic review of the evidence" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083240). Tobacco Induced Diseases. 18 (March): 20. doi:10.18332/tid/119324 (https://doi.org/10.18332%2Ftid%2F11932 4). PMC 7083240 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083240). PMID 32206052 (https://pubmed.ncbi.nlm.nih.gov/32206052). 32. Cheung E (13 March 2020). "Some recovered Covid-19 patients may have lung damage, doctors say" (https://www.scmp.com/news/hong-kong/health-environment/article/3074988/coro navirus-some-recovered-patients-may-have). South China Morning Post. Archived (https://we b.archive.org/web/20200315172445/https://www.scmp.com/news/hong-kong/health-environme nt/article/3074988/coronavirus-some-recovered-patients-may-have) from the original on 15 March 2020. Retrieved 15 March 2020. 33. Servick K (8 April 2020). "For survivors of severe COVID-19, beating the virus is just the beginning" (https://www.sciencemag.org/news/2020/04/survivors-severe-covid-19-beating-viru s-just-beginning). Science. doi:10.1126/science.abc1486 (https://doi.org/10.1126%2Fscience.a bc1486). ISSN 0036-8075 (https://www.worldcat.org/issn/0036-8075). 34. "Sala de Situación COVID-19 Nuevo Coronavirus 2019 Novedades al 07/05 - 18 hs- SE 19" (h ttps://www.argentina.gob.ar/sites/default/files/sala_7_mayo.pdf) (PDF) (in Spanish). 7 May 2020. 35. Health, Australian Government Department of (20 May 2020). "COVID-19 cases by age group and sex" (https://www.health.gov.au/resources/covid-19-cases-by-age-group-and-sex). Australian Government Department of Health. Retrieved 20 May 2020. Health, Australian Government Department of (20 May 2020). "COVID-19 deaths by age group and sex" (https:// www.health.gov.au/resources/covid-19-deaths-by-age-group-and-sex). Australian Government Department of Health. Retrieved 20 May 2020. 36. "Coronavirus Disease 2019 (COVID-19) DAILY EPIDEMIOLOGY UPDATE Updated: 19 May, 2020, 11:00 AM ET" (https://www.canada.ca/content/dam/phac-aspc/documents/services/dise ases/2019-novel-coronavirus-infection/surv-covid19-epi-update-eng.pdf) (PDF). Public Health Agency of Canada. 19 May 2020. Retrieved 20 May 2020. 37. "16° informe epidemiológico COVID-19" (https://www.minsal.cl/18-informe-epidemiologico-covi d-19/). Ministerio de Salud – Gobierno de Chile. https://cdn.digital.gob.cl/public_files/Campañas/Corona- Virus/Reportes/17.05.2020_Reporte_Covid19.pdf 38. "Coronavirus Colombia" (https://www.ins.gov.co/Noticias/Paginas/Coronavirus.aspx). www.ins.gov.co. 39. COVID-19 i Danmark: Epidemiologisk overvågningsrapport den 19. maj 2020 (https://files.ssi.d k/COVID19-overvaagningsrapport-19052020-d2l8) (Report) (in Danish). Statens Serum Institut. 19 May 2020. Retrieved 20 May 2020. 40. "Experience" (https://experience.arcgis.com/experience/92e9bb33fac744c9a084381fc35aa3c 7). experience.arcgis.com. https://thl.fi/fi/web/infektiotaudit-ja- rokotukset/ajankohtaista/ajankohtaista-koronaviruksesta-covid-19/tilannekatsaus- koronaviruksesta 41. "Coronavirus Disease 2019 (COVID-19) Daily Situation Report of the Robert Koch Institute 21/05/2020 - UPDATED STATUS FOR GERMANY" (https://www.rki.de/DE/Content/InfAZ/N/Ne uartiges_Coronavirus/Situationsberichte/2020-05-21-en.pdf?__blob=publicationFile) (PDF). Robert Koch Institute. 42. " משרד הבריאות- ( "קורונהhttps://t.me/MOHreport/4421?single). Ministry of Health (Israel). 3 May 2020. Retrieved 5 May 2020. 43. "Integrated surveillance of COVID-19 in Italy" (https://www.epicentro.iss.it/en/coronavirus/bollet tino/Infografica_27maggio%20ENG.pdf) (PDF). Istituto Superiore di Sanità. 44. "Coronavirus Disease (COVID-19) Situation Report in Japan" (https://toyokeizai.net/sp/visual/t ko/covid19/en). toyokeizai.net. 45. COVID-19 Tablero México - CONACYT (https://coronavirus.gob.mx/datos/) (Report) (in Spanish). Mexico City: CONACYT. 24 May 2020. Retrieved 24 May 2020. 46. Epidemiologische situatie COVID-19 in Nederland 20 mei 2020 (https://www.rivm.nl/document en/epidemiologische-situatie-covid-19-in-nederland-20-mei-2020) (Report) (in Dutch). Bilthoven: Rijksinstituut voor Volksgezondheid en Milie. 20 May 2020. Retrieved 20 May 2020. 47. "COVID-19 Dagsrapport fredag 20. mai 2020" (https://www.fhi.no/contentassets/ca5914bd0aa 14e15a17f8a7d48fa306a/2020.05.20-dagsrapport-norge-covid-19.pdf) (PDF). Folkehelseinstituttet. 20 May 2020. Retrieved 20 May 2020. 48. https://www.doh.gov.ph/covid19tracker 49. "NOVO CORONAVÍRUS COVID-19 RELATÓRIO DE SITUAÇÃO" (https://covid19.min-saude. pt/wp-content/uploads/2020/05/79_DGS_boletim_20200520.pdf) (PDF) (in Portuguese). 20 May 2020. Retrieved 20 May 2020. 50. "FOHM Covid-19" (https://experience.arcgis.com/experience/09f821667ce64bf7be6f9f87457ed 9aa). Public Health Agency of Sweden. Retrieved 20 May 2020. 51. "Todesfälle in der Schweiz nach Altersgruppen" (https://datawrapper.dwcdn.net/IJC8v/45). datawrapper.dwcdn.net. 20 May 2020. Retrieved 20 May 2020. 52. "Case data | Colorado COVID-19 Updates" (https://covid19.colorado.gov/data/case-data). covid19.colorado.gov. 53. "COVID-19 confirmed cases and deaths by age group | Connecticut Data" (https://data.ct.gov/ Health-and-Human-Services/COVID-19-confirmed-cases-and-deaths-by-age-group/ypz6- 8qyf). data.ct.gov. 20 May 2020. Retrieved 20 May 2020. 54. "Tableau Public" (https://public.tableau.com/profile/idaho.division.of.public.health#!/vizhome/D PHIdahoCOVID-19Dashboard_V2/Story1). public.tableau.com. 55. "COVID-19 Case Demographics - the Indiana Data Hub" (https://hub.mph.in.gov/dataset/covid- 19-case-demographics). hub.mph.in.gov. 56. "KDPH COVID-19 Dashboard" (https://kygeonet.maps.arcgis.com/apps/opsdashboard/index.ht ml#/543ac64bc40445918cf8bc34dc40e334). Kygeonet.maps.arcgis.com. Retrieved 21 May 2020. 57. https://coronavirus.maryland.gov Probable but not lab-confirmed deaths not included 58. "COVID-19 Response Reporting" (https://www.mass.gov/info-details/covid-19-response-reporti ng). Mass.gov. 20 May 2020. Retrieved 20 May 2020.